Walleye Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Sell |
141,191
-122,066
| -46% | -$2.05M | 0.01% | 583 |
|
|
2025
Q1 | $4.05M | Sell |
263,257
-745,626
| -74% | -$11.5M | 0.02% | 405 |
|
|
2024
Q4 | $22.2M | Sell |
1,008,883
-94,177
| -9% | -$2.08M | 0.05% | 120 |
|
|
2024
Q3 | $19.9M | Buy |
1,103,060
+949,026
| +616% | +$17.1M | 0.04% | 109 |
|
|
2024
Q2 | $2.5M | Buy |
154,034
+152,639
| +10,942% | +$2.48M | ﹤0.01% | 712 |
|
|
2024
Q1 | $19.7K | Sell |
1,395
-225,056
| -99% | -$3.18M | ﹤0.01% | 2266 |
|
|
2023
Q4 | $2.36M | Buy |
226,451
+187,581
| +483% | +$1.96M | 0.01% | 585 |
|
|
2023
Q3 | $396K | Buy |
+38,870
| New | +$396K | ﹤0.01% | 1222 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2813 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2604 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2737 |
|
|
2020
Q1 | – | Sell |
-13,752
| Closed | -$135K | – | 926 |
|
|
2019
Q4 | $135K | Sell |
13,752
-136,318
| -91% | -$1.34M | 0.01% | 436 |
|
|
2019
Q3 | $1.03M | Buy |
+150,070
| New | +$1.03M | 0.06% | 43 |
|
|
2019
Q2 | – | Sell |
-16,218
| Closed | -$254K | – | 878 |
|
|
2019
Q1 | $254K | Buy |
+16,218
| New | +$254K | 0.04% | 56 |
|